Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Vijay B. SamantPresident & CEO1,210,7761.34%2015-01-19
Dr. Larry R. Smith,PhDVP, Vaccine Research244,9770.27%2015-01-19
Dr. Igor P. Bilinsky, PhDSr VP, Corporate Development196,3130.22%2015-01-19
Mr. Anthony A. RamosVP, Chief Accounting Officer147,5080.16%2015-01-21
Jill M. BroadfootSr Vice President, CFO, Sec145,6490.16%2013-04-01
Dr. Alain P. Rolland,Pharm.D.,PhDExec VP, Product Development127,5830.14%2013-08-22
Dr. R. Gordon Douglas,M.D.Director100,7810.11%2014-05-22
Dr. Robert C. Merton,PhDDirector83,281less than 0.1%2014-05-22
Mr. Gary A. LyonsDirector70,781less than 0.1%2014-05-22
Dr. David C. Kaslow,M.D.Chief Scientific Officer43,405less than 0.1%2006-02-22

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
Ramos Anthony AlanVP, Chief Accounting Officer2015-01-21Sell428147,508$1.090.5-9.17Link
SAMANT VIJAY BPresident & CEO
(Click for the stocks that their CEOs have bought)
2015-01-13Sell4,737910,776$1.125.3-11.61Link
BILINSKY IGORSr VP, Corporate Development2015-01-12Sell1,335126,313$1.161.5-14.66Link
SMITH LAWRENCE RUSSELLVP, Vaccine Research2015-01-12Sell1,912174,977$1.162.2-14.66Link
Ramos Anthony AlanVP, Chief Accounting Officer2014-10-21Sell42887,936$1.180.5-16.1Link
SMITH LAWRENCE RUSSELLVP, Vaccine Research2014-10-13Sell1,912176,889$1.082.1-8.33Link
SAMANT VIJAY BPresident & CEO2014-10-13Sell4,738936,513$1.135.4-12.39Link
BILINSKY IGORSr VP, Corporate Development2014-10-13Sell1,335127,648$1.081.4-8.33Link
BILINSKY IGORSenior VP, Corporate Dev't2014-08-26Sell12,500128,983$1.2515.6-20.8Link
SMITH LAWRENCE RUSSELLVP, Vaccine Research2014-08-26Sell12,500178,801$1.2515.6-20.8Link
Ramos Anthony AlanVP, Chief Accounting Officer2014-08-26Sell12,50088,364$1.2515.6-20.8Link
Ramos Anthony AlanVP, Chief Accounting Officer2014-07-21Sell428100,864$1.290.6-23.26Link
SAMANT VIJAY BPresident & CEO2014-07-14Sell4,737941,251$1.175.5-15.38Link
SMITH LAWRENCE RUSSELLVP, Vaccine Research2014-07-11Sell1,912191,301$1.162.2-14.66Link
BILINSKY IGORSenior VP, Corporate Dev't2014-07-11Sell1,335141,483$1.161.5-14.66Link
Ramos Anthony AlanVP, Chief Accounting Officer2014-04-21Sell428101,292$1.220.5-18.85Link
SAMANT VIJAY BPresident & CEO2014-04-14Sell4,738945,988$1.165.5-14.66Link
BILINSKY IGORSenior VP, Corporate Dev't2014-04-11Sell1,150142,818$1.211.4-18.18Link
SMITH LAWRENCE RUSSELLVP, Vaccine Research2014-04-11Sell1,912193,213$1.212.3-18.18Link
SAMANT VIJAY BPresident & CEO2014-01-10Buy330,000950,726$1.42468.6-30.28Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK